Coya Therapeutics secured $11.1M to support commercial readiness for COYA 302, an experimental ALS therapy. COYA 302 is designed to rebalance immune activity that may contribute to inflammation in ALS ...
The ALS Better Care Act aims to improve access to quality medical care for ALS patients. Current Medicare reimbursement issues create barriers to essential ALS care. The bill proposes an $800 Medicare ...
More than two hours into a sold-out concert at Austin’s Paramount Theatre last week, a tall, graceful woman strolled onto center stage, sat down at the piano, and received a thunderous, standing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results